Comparison Between Sevoflurane and Propofol for Maintenance of Sedation During ERCP

Sponsor
Sindh Institute of Urology and Transplantation (Other)
Overall Status
Completed
CT.gov ID
NCT05996588
Collaborator
(none)
86
1
2
10.6
8.1

Study Details

Study Description

Brief Summary

After approval of ethical committee of Sindh Institute of Urology & Transplantation (SIUT), 86 patients were enrolled for the elective endoscopic retrograde cholangiopancreatography (ERCP). Randomization was done by a computer-generated randomization table. Patients were divided in two groups based on agents used for the research study. Both the groups were induced by injection midazolam 0.06 mg/kg body weight and injection nalbuphine 0.1 mg/kg body weight. In group A, anesthesia was maintained by Sevoflurane inhalation via nasal prongs with oxygen to achieve minimum alveolar concentration (MAC) approximately 0.25%. Whereas, in Group B propofol infusion at 50 ug/Kg/min started for maintenance of anaesthesia. Ketamine 0.5mg/kg intravenously was used to rescue the sedation level in both groups

Condition or Disease Intervention/Treatment Phase
Phase 4

Detailed Description

After approval of ethical committee of SIUT, 86 patients were enrolled for the elective endoscopic retrograde cholangiopancreatography (ERCP). Pre-operative assessment was done by history of patients, general physical examination, systematic examination, and laboratory investigations. Randomization was done by a computer-generated randomization table. Patients were divided in two groups based on agents used for the research study. Both the groups were induced by injection midazolam 0.06 mg/kg body weight and injection nalbuphine 0.1 mg/kg body weight. In group A, anesthesia was maintained by Sevoflurane inhalation via nasal prongs with oxygen to achieve minimum alveolar concentration (MAC) approximately 0.25%. Whereas, in Group B propofol infusion at 50 ug/Kilogram/min started for maintenance of anaesthesia.

When Ramsay Sedation Scale 5 is achieved then the endoscopist was allowed to insert endoscope. Injection Ketamine 0.5 mg/kg body weight was used for rescue sedation level. Upon arrival in operation theatre standard monitoring which includes pulse oximeter (SPO2), noninvasive blood pressure (NIBP), electrocardiogram (ECG) electrodes were applied, and baseline readings will be recorded. After that venous access was secured on a non-dominant hand by 20 Gauge IV cannula. Ringer's lactate or normal saline was then started at 8 ml/kg/hour and O2 was given by nasal prongs at 4 L/min. All baseline parameters were taken, after that readings were taken at 5 min, 10 min, 15 min, 20 min and so on till procedure ends.

Complications such as respiratory depression, coughing, gagging, nausea and vomiting were recorded during the procedure and treated accordingly. If SpO2 went down below 92% for more than 10 seconds or patient developed apnea, it was considered oxygen desaturation.

Oxygen desaturation was managed by O2 inhalation and supporting airway. A heart rate under 40 beats per minute was considered bradycardia and it will be managed by inj Atropine 10 ug/Kilogram intravenously (I/V). Mean arterial pressures level that is lower than 60 mmHg or 20% less than the baseline was regarded as hypotension and it was managed by fluid bolus or vasopressors.

After the procedure, patients were awakened and shifted to recovery room. Complications such as respiratory depression, coughing, gagging, nausea and vomiting were recorded and treated accordingly.

Study Design

Study Type:
Interventional
Actual Enrollment :
86 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparison Between Inhalational Anesthetic (Sevoflurane) and Intravenous Anesthetic (Propofol Infusion) for Maintenance of Sedation During Endoscopic Retrograde Cholangiopancreatography
Actual Study Start Date :
Jan 5, 2022
Actual Primary Completion Date :
Nov 25, 2022
Actual Study Completion Date :
Nov 25, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Propofol

Propofol at a rate of 50 microgram/kg/min

Drug: Propofol 1 % Injectable Suspension
Propofol 1 % Injectable Suspension at a rate of 50 microgram/kg/min intravenously
Other Names:
  • Propofol
  • Experimental: Sevoflurane

    Sevoflurane inhalation with oxygen via nasal prongs at a concentration 4-5% to achieve a MAC of 0.25

    Drug: Sevoflurane
    Sevoflurane inhalation anaesthetic at a concentration of 4-5% to achieve a MAC of 0.25
    Other Names:
  • Sevoflurane inhalation anaesthetic
  • Outcome Measures

    Primary Outcome Measures

    1. Ramsay sedation score [0-2 hours]

      Clinical Score Patient's Characteristics Awake; agitated or restless or both Awake; cooperative, oriented, and tranquil Awake but responds to commands only Asleep; brisk response to light glabellar tap or loud auditory stimulus Asleep; sluggish response to light glabellar tap or loud auditory stimulus Asleep; no response to glabellar tap or loud auditory stimulus

    2. Heart rate [0-2 hours]

      Heart rate via vitals monitoring device

    3. Mean arterial blood pressure [0-2 hours]

      Mean arterial blood pressure via a non-invasive blood pressure monitor

    4. Oxygen saturation [0-2 hours]

      Oxygen saturation via a pulse oximeter

    5. Respiratory rate [0-2 hours]

      Respiratory rate via a vitals monitoring device

    Other Outcome Measures

    1. Number of patients with post operative nausea [0-2 hours]

      Feeling of patient to vomit out

    2. Number of patients with post operative vomiting [0-2 hours]

      Expulsion of stomach contents

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Patients between age group of 20-60 years

    • Both male and female patients.

    • American Society of Anesthesiologist (ASA) physical status I-II

    • Elective ERCP procedure.

    Exclusion Criteria:
    • Patients allergic to any study drug.

    • American Society of Anesthesiology (ASA) Physical status III-IV

    • Patients with uncontrolled Diabetes Mellitus,

    • Hypertension and renal insufficiency.

    • Body mass index (BMI) over 36 Kilogram/m2 (Morbid obesity)

    • Obstructive Sleep Apnea

    • Gastroesophageal reflux disease (GERD)

    • Pregnancy

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Syed Muhammad Abbas Karachi Sindh Pakistan 74200

    Sponsors and Collaborators

    • Sindh Institute of Urology and Transplantation

    Investigators

    • Study Chair: Muhammad Q Abbas, FCPS, Professor Dept of Anaesthesiology

    Study Documents (Full-Text)

    More Information

    Publications

    None provided.
    Responsible Party:
    Syed Muhammad Abbas, Associate Professor, Department of Anaesthesia, Sindh Institute of Urology and Transplantation
    ClinicalTrials.gov Identifier:
    NCT05996588
    Other Study ID Numbers:
    • SIUT-ERC-2021/A-325
    First Posted:
    Aug 18, 2023
    Last Update Posted:
    Aug 18, 2023
    Last Verified:
    Aug 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    Yes
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    Yes
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 18, 2023